Joint Pain Injections Market Revenue Growth Forecast To Reach $10.95 Billion By 2030 At 12.3% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Joint Pain Injections Market Expected To Change From 2026 To 2030?
The joint pain injections market has witnessed significant expansion in recent times. Its size is expected to increase from $6.12 billion in 2025 to $6.89 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. This historical growth can be linked to factors such as the increasing prevalence of arthritis and joint disorders, an aging global population, a rising demand for minimally invasive pain treatments, growing awareness of regenerative therapies, and the expansion of orthopedic specialty care.
The joint pain injections market is anticipated to experience substantial growth in the coming years. It is forecast to expand to $10.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.3%. This expansion during the forecast period is driven by factors such as the increasing adoption of biologic pain therapies, a rising focus on personalized medicine, the expansion of sports injury management, growing investments in regenerative medicine, and an increasing preference for non-opioid pain management. Significant trends expected in this period include the rising adoption of non-surgical pain management therapies, increased utilization of hyaluronic acid and PRP injections, a growing demand for personalized pain treatment approaches, the expansion of regenerative medicine-based injections, and an enhanced focus on outpatient pain relief solutions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report
Which Factors Are Influencing The Growth Of The Joint Pain Injections Market?
An increasing incidence of arthritis and musculoskeletal conditions is expected to boost the expansion of the joint pain injections market. Globally, musculoskeletal disorders represent the primary contributor to disability, with low back pain alone accounting for the most frequent cause of impairment across 160 nations. Injections are frequently administered to patients to alleviate pain and manage inflammatory conditions. As an illustration, the Institute for Health Metrics and Evaluation (IHME), an independent U.S.-based health research body, released a report in August 2023 predicting that close to 1 billion individuals will be living with osteoarthritis by the year 2050. Consequently, the growing occurrence of arthritis and musculoskeletal disorders serves as a key impetus for the joint pain injections market.
What Segment Categories Shape The Joint Pain Injections Market Segment Landscape?
The joint pain injections market covered in this report is segmented –
1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections
2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies
Subsegments:
1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections
2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections
Which Trends Are Influencing Demand In The Joint Pain Injections Market?
Major companies in the joint pain injection sector are concentrating on developing innovations, such as single-injection formulations, to enhance patient convenience. This type of formulation describes a drug delivery system designed to administer a specific dose of medication in one injection, providing sustained therapeutic effects over a prolonged period without requiring multiple doses. For example, in July 2024, LG Chem Ltd., a South Korea-based chemicals company, introduced Synovian, a new knee osteoarthritis treatment in China that offers a convenient single-injection formulation, making it the first of its kind in the country. The product intends to access a significant market estimated at around KRW 200 billion (approximately USD 150 million). Developed with proprietary technology, it exemplifies innovation in meeting patient needs, with a focus on delivering effective relief with minimal administration hassle.
Who Are The Companies Operating Across The Joint Pain Injections Market Value Chain?
Major companies operating in the joint pain injections market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus Inc., Flexion Therapeutics Inc., Ferring Pharmaceuticals Inc., Sanofi S.A., AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Merck & Co. Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Limited, Wockhardt Ltd., Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Bayer AG, Eli Lilly and Company, Ipsen SA, Takeda Pharmaceutical Company Limited, AstraZeneca plc
Get The Full Joint Pain Injections Market Report:
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report
Which Region Is The Leading Market For The Joint Pain Injections Market?
North America was the largest region in the joint pain injections market in 2025. The regions covered in the joint pain injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Joint Pain Injections Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report
Browse Through More Reports Similar to the Global Joint Pain Injections Market 2026, By The Business Research Company
Pain Management Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report
Bone And Joint Health Supplements Market Report 2026
Non Opioid Pain Patch Market Report 2026
https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
